By Alla Katsnelson

For the past decade, many researchers have complained bitterly that a trio of hotly contested patents has thwarted potentially life-saving research involving embryonic stem cells. Now, a decision to overturn one of these claims may radically change the notion of what’s patentable in the life sciences. (Click here to continue reading)

Image: Ayacop via Wikimedia Commons